Universal. Safe. Scalable. Engineered to reach every patient.
Encelta is founded on deep scientific expertise and a key discovery that unlocks a powerful, previously inaccessible aspect of T cell biology. This breakthrough has laid the foundation for a new kind of T cell therapy that we are calling “TPRO Cells“, designed with both clinical impact and real-world practicality in mind.
Our Team
Breakthrough science needs the right team. That’s why we’ve built a strong group of expert scientists, drug developers and operators to guide this innovation forward. From manufacturing to commercial strategy we are committed to getting it right and redefining the cell therapy industry.
Meet the Team
Our Mission
At Encelta, our mission is to make cell therapy accessible-now and in the future. We are unlocking the full potential of immunotherapies through a scalable, off-the-shelf platform built to meet real-world needs and designed to serve any patient in need.
Check Our Progress
Menu
Our universal TPRO cells are engineered with one goal in mind: to enhance the therapeutic activity of T cell engagers (TCEs).
Encelta AG 2025. All Rights Reserved.
